During the past decade, Fundacion de Investigacion de Diego conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion de Investigacion de Diego" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored, "Pharmasset" with 3 trials sponsored, "Conatus Pharmaceuticals Inc." with 2 trials sponsored and "Human Genome Sciences Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion de Investigacion de Diego" #1 collaborator was "Novartis" with 2 trials as a collaborator, "ViroChem Pharma" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Tibotec, Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion de Investigacion de Diego" are "Hepatitis C" (10 trials), "Chronic Hepatitis C" (4 trials), "Hepatitis C, Chronic" (3 trials), "Chronic Hepatitis" (2 trials) and "Hepatitis B" (2 trials). Many other conditions were trialed in "Fundacion de Investigacion de Diego" in a lesser frequency.

Most popular intervention types in "Fundacion de Investigacion de Diego" are "Drug" (21 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ribavirin" (6 trials), "Placebo" (3 trials), "RBV" (3 trials), "peginterferon alfa-2a" (3 trials) and "ribavirin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion de Investigacion de Diego" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion de Investigacion de Diego". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Fundacion de Investigacion de Diego, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion de Investigacion de Diego, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".